XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
  CTVS
  Transplantation
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM
Research Article

CTVS Channel
subscribe to CTVS newsletter

Latest Research : Surgery : CTVS

   DISCUSS   |   EMAIL   |   PRINT
Lung-volume reduction surgery strongly recommended for end-stage emphysema patients
Jan 30, 2006 - 8:23:00 PM, Reviewed by: Dr. Rashmi Yadav

�We now know the improvements resulting from lung-volume reduction surgery last longer in some patients. This is an operation we should strongly be recommending for many patients with end-stage emphysema.�

 
Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented yesterday by a Saint Louis University cardiothoracic surgeon.

The findings confirm earlier study results and offer new hope to select patients, says Keith Naunheim, M.D., director of the division of cardiothoracic surgery at Saint Louis University School of Medicine and principal investigator of the eight-year long National Emphysema Treatment Trial.

�This validates the early results reported in 2003 � the surgery is still a bad idea for some patients, but it is still a good idea for other patients,� says Naunheim, who presented his findings yesterday at the 42nd Society of Thoracic Surgeons Annual Meeting in Chicago.

�We now know the improvements resulting from lung-volume reduction surgery last longer in some patients. This is an operation we should strongly be recommending for many patients with end-stage emphysema.�

Lung-volume reduction surgery is a procedure that removes up to a third of the diseased portion of the lung. The study examined mortality rates, ability to exercise and quality of life of patients who had undergone lung-volume reduction surgery after two years and up to five years, Naunheim said.

Five years after undergoing lung volume reduction, those with emphysema in the upper lobes of their lungs showed improvement in survival, exercise and quality of life when compared to patients who were treated with standard medical therapy. These findings are consistent with those researchers saw after the two-year mark and demonstrate that the benefit from the operation is durable. Of the 1,218 patients enrolled in the national emphysema study, 24 percent had higher survival rates after to the lung surgery and 58 percent were in a group that demonstrated improved exercise and quality of life.

Naunheim says he was slightly surprised by how well the upper-lobe emphysema patients with a lower ability to exercise did after the surgery in comparison to similar patients in the study who did not undergo surgery.

�Based on our earlier findings, we knew those with upper-lobe emphysema would see some improvement,� Naunheim says. �We now know (the low exercise group) saw the most improvement in ability to exercise and in quality of life.�

The low-exercise group saw more improvement than the high-exercise group �because they had more room for improvement,� Naunheim says.

Those who did worst after the surgery had emphysema distributed throughout the lungs and/or in the lower portion of their lungs and had higher exercise capacities.

�Based on these results, we would not recommend these patients undergo lung-volume reduction,� Naunheim says, noting that those patients didn�t experience improvements in any of the three areas.

The study is the first of its kind to examine the safety and efficacy of lung-volume reduction surgery on a nation-wide basis. It was also the first time that the National Institutes of Health teamed with the Centers for Medicare and Medicaid Services in 1996 to organize a national study. For this emphysema trial, patients with severe emphysema at 17 clinical sites were randomly divided into two groups: one underwent lung volume reduction surgery while the other received medical therapy only.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others.

 

- The findings were presented findings yesterday at the 42nd Society of Thoracic Surgeons Annual Meeting in Chicago.
 

http://www.slu.edu/index.html

 
Subscribe to CTVS Newsletter
E-mail Address:

 

The study is the first of its kind to examine the safety and efficacy of lung-volume reduction surgery on a nation-wide basis. It was also the first time that the National Institutes of Health teamed with the Centers for Medicare and Medicaid Services in 1996 to organize a national study. For this emphysema trial, patients with severe emphysema at 17 clinical sites were randomly divided into two groups: one underwent lung volume reduction surgery while the other received medical therapy only.
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others.


Related CTVS News

Older blood associated with worse outcomes after repeat heart surgery
Preventing spinal cord injury during aortic surgery
Drug-eluding stents seems to be a viable alternative to CABG for patients with severe coronary artery disease
Women's increased risk of mortality after coronary artery bypass surgery is due to infections
Different Drug-Releasing Coronary Stents Show Similar Effectiveness
A novel collapsible heart valve can revolutionize the present invasive open heart surgery in children
Lung-volume reduction surgery strongly recommended for end-stage emphysema patients
Causes of cognitive loss following coronary artery bypass surgery identified
Minimizing aortic manipulations can significantly reduce the incidence of cognitive deficits in CABG patients
Drug-eluting stents may cause allergic reactions


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us